Synthesis and Characterization of ULK1/2 Kinase Inhibitors that Inhibit Autophagy and Upregulate Expression of Major Histocompatibility Complex I for the Treatment of Non-Small Cell Lung CancerFabiana Izidro Layng, Nicholas D. P. Cosford|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 1
ULK1/2 Inhibitors that Degrade ATG13 Effectively Target KRAS-Mutant CancersPatrick M. Hagan, Nicholas D. P. Cosford|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 0